Am J Epidemiol 2002; 156:714-719.
Copyright © 2002 by the
Johns Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Age and the Burden of Death Attributable to Diabetes in the United States
1 Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
2 Office of Analysis, Epidemiology and Health Promotion, National Center for Health Statistics, Centers for Disease Control and Prevention, Atlanta, GA.
3 Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, MD.
4 Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD.
Diabetes is a well-established cause of cardiovascular disease (CVD) and all-cause mortality. The burden of death attributable to diabetes in the United States is not well quantified, particularly with regard to age. The authors analyzed data from the Second National Health and Nutrition Examination Survey (NHANES II) (1976–1980) and the NHANES II Mortality Study, in which a nationally representative cohort of 9,250 adults aged 30–75 years was followed for 12–16 years, to determine all-cause and cause-specific mortality. Overall, between 1976 and 1980, the prevalence of diagnosed diabetes was 4.3%. By 1992, the relative hazard of all-cause mortality was 1.9 (95% confidence interval: 1.5, 2.3), and the population attributable risk (PAR) was 3.6%. The relative hazard of CVD mortality was 2.3 (95% confidence interval: 1.8, 2.8), and the PAR was 5.2%. Including participants with undiagnosed diabetes in the estimates increased the PAR for all-cause mortality to 5.1% and that for CVD mortality to 6.8%. Women had a higher prevalence of diagnosed diabetes than men and a greater relative hazard of death than nondiabetic women, leading to a higher PAR for women (3.8% for all causes and 7.3% for CVD) versus men (3.3% for all causes and 3.8% for CVD). These data suggest that diabetes accounts for at least 3.6% of all deaths and 5.2% of CVD deaths in US adults. Improvements in diabetes prevention and treatment should produce noticeable effects on US life expectancy.
diabetes mellitus; mortality
Abbreviations: Abbreviations: CI, confidence interval; NHANES II, Second National Health and Nutrition Examination Survey; PAR, population attributable risk.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Davidson and C. G. Parkin Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes Diabetes Care, November 1, 2009; 32(suppl_2): S331 - S333. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Beardsall, K. K. Ong, N. Murphy, M. L. Ahmed, J. H. Zhao, M. W. Peeters, and D. B. Dunger Heritability of Childhood Weight Gain from Birth and Risk Markers for Adult Metabolic Disease in Prepubertal Twins J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3708 - 3713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Lee, S. J. Chung, V. A. Lopez, and N. D. Wong Association of FVC and Total Mortality in US Adults With Metabolic Syndrome and Diabetes Chest, July 1, 2009; 136(1): 171 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Klug, D. J. Toobert, and M. Fogerty Healthy ChangesTM for Living With Diabetes: An Evidence-Based Community Diabetes Self-management Program The Diabetes Educator, November 1, 2008; 34(6): 1053 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gaede, W. J. Valentine, A. J. Palmer, D. M.D. Tucker, M. Lammert, H.-H. Parving, and O. Pedersen Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes: Results and projections from the Steno-2 study Diabetes Care, August 1, 2008; 31(8): 1510 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Lee Why Young Adults Hold the Key to Assessing the Obesity Epidemic in Children Arch Pediatr Adolesc Med, July 1, 2008; 162(7): 682 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L.M. Barr, P. Z. Zimmet, T. A. Welborn, D. Jolley, D. J. Magliano, D. W. Dunstan, A. J. Cameron, T. Dwyer, H. R. Taylor, A. M. Tonkin, et al. Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Circulation, July 10, 2007; 116(2): 151 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Ackermann and D. G. Marrero Adapting the Diabetes Prevention Program Lifestyle Intervention for Delivery in the Community: The YMCA Model The Diabetes Educator, January 1, 2007; 33(1): 69 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. Bloomfield, M. H. Oliver, and J. E. Harding Effects of twinning, birth size, and postnatal growth on glucose tolerance and hypothalamic-pituitary-adrenal function in postpubertal sheep Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E231 - E237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nicolucci, S. Greenfield, and S. Mattke Selecting indicators for the quality of diabetes care at the health systems level in OECD countries Int. J. Qual. Health Care, September 1, 2006; 18(suppl_1): 26 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.M. V. Narayan Glycemic Control and Cardiovascular Disease in Patients With Type 1 Diabetes Clin. Diabetes, April 1, 2006; 24(2): 88 - 89. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Chaowalit, A. L. Arruda, R. B. McCully, K. R. Bailey, and P. A. Pellikka Dobutamine Stress Echocardiography in Patients With Diabetes Mellitus: Enhanced Prognostic Prediction Using a Simple Risk Score J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1029 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Egede, P. J. Nietert, and D. Zheng Depression and All-Cause and Coronary Heart Disease Mortality Among Adults With and Without Diabetes Diabetes Care, June 1, 2005; 28(6): 1339 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.M. V. Narayan Psychosocial Risk Factors for Acute Myocardial Infarction Clin. Diabetes, January 1, 2005; 23(1): 35 - 36. [Full Text] [PDF]
|
|
|
|
 |
|
 C. D MacLean, B. Littenberg, M. Gagnon, M. Reardon, P. D Turner, and C. Jordan The Vermont Diabetes Information System (VDIS): study design and subject recruitment for a cluster randomized trial of a decision support system in a regional sample of primary care practices Clinical Trials, December 1, 2004; 1(6): 532 - 544. [Abstract] [PDF]
|
|
|
|
|
|
K.M. V. Narayan "Polypill" for Cardiovascular Disease Prevention Clin. Diabetes, October 1, 2004; 22(4): 157 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Malik, N. D. Wong, S. S. Franklin, T. V. Kamath, G. J. L'Italien, J. R. Pio, and G. R. Williams Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults Circulation, September 7, 2004; 110(10): 1245 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.M. V. Narayan The Steno Diabetes Study Clin. Diabetes, January 1, 2004; 22(1): 34 - 35. [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. V. Narayan, J. P. Boyle, T. J. Thompson, S. W. Sorensen, and D. F. Williamson Lifetime Risk for Diabetes Mellitus in the United States JAMA, October 8, 2003; 290(14): 1884 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Aekplakorn, R. P. Stolk, B. Neal, P. Suriyawongpaisal, V. Chongsuvivatwong, S. Cheepudomwit, and M. Woodward The Prevalence and Management of Diabetes in Thai Adults: The International Collaborative Study of Cardiovascular Disease in Asia Diabetes Care, October 1, 2003; 26(10): 2758 - 2763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Dhatariya Type 2 diabetes is cardiovascular disease J R Soc Med, August 1, 2003; 96(8): 371 - 372. [Full Text] [PDF]
|
|
|
|
|
|
D. A. Alter, Y. Khaykin, P. C. Austin, J. V. Tu, and J. E. Hux Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat? Diabetes Care, May 1, 2003; 26(5): 1427 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Solomon Reducing Cardiovascular Risk in Type 2 Diabetes N. Engl. J. Med., January 30, 2003; 348(5): 457 - 459. [Full Text] [PDF]
|
|